Your session is about to expire
← Back to Search
IMD Placement and Retrieval for Breast Cancer
Study Summary
This trial will evaluate the safety and feasibility of implanting a microdevice to deliver microdoses of cancer drugs to assess effectiveness against TNBC.
- Breast Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any vacant opportunities for people to participate in this research project?
"According to clinicaltrials.gov, recruitment for this trial has ceased since the last update on March 8th 2023. However, there are currently 4934 other medical trials looking for participants."
What adverse effects could arise from IMD Placement and Retrieval?
"Due to the preliminary nature of this clinical trial, our team at Power rated IMD Placement and Retrieval's safety a 1 out of 3. At present, there is only limited data supporting its efficacy and safety profiles."
What objectives are researchers trying to achieve with this research endeavor?
"This trial will last up to 80 hours and the primary objective is to track how many participants have a successful procedure. Secondly, there are two additional objectives: correlating local intratumoral response with the microdevice and systemic neoadjuvant therapy (RCB Class) using descriptive statistics; as well as tracking response to systemic neoadjuvant therapy through RCB Score."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger